| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.568 | 9.196 | - | 9.038 | 14.353 | 12.995 | 17.838 | 19.384 | 10.401 | 10.665 |
| Total Income - EUR | 15.568 | 9.196 | - | 9.038 | 15.301 | 13.822 | 17.838 | 19.384 | 10.401 | 10.665 |
| Total Expenses - EUR | 6.802 | 7.259 | - | 8.023 | 6.236 | 9.120 | 6.453 | 5.090 | 5.965 | 5.603 |
| Gross Profit/Loss - EUR | 8.766 | 1.937 | - | 1.015 | 9.065 | 4.703 | 11.385 | 14.294 | 4.436 | 5.062 |
| Net Profit/Loss - EUR | 8.301 | 1.674 | - | 744 | 8.635 | 4.438 | 10.860 | 13.724 | 3.811 | 4.216 |
| Employees | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Carisma Transmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.393 | 16.913 | - | 13.233 | 8.064 | 2.365 | 0 | 0 | 0 | 0 |
| Current Assets | 36.883 | 5.137 | - | 536 | 14.110 | 23.814 | 12.682 | 14.124 | 5.841 | 4.779 |
| Inventories | 335 | 582 | - | 0 | 31 | 0 | 0 | 0 | 0 | 161 |
| Receivables | 3.604 | 3.509 | - | 145 | 142 | 611 | 597 | 11.904 | 358 | 228 |
| Cash | 32.944 | 1.045 | - | 391 | 13.937 | 23.203 | 12.085 | 2.220 | 5.483 | 4.390 |
| Shareholders Funds | 54.473 | 9.943 | - | 13.690 | 22.059 | 26.079 | 12.103 | 13.772 | 5.816 | 4.264 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.613 | 13.897 | - | 79 | 114 | 100 | 579 | 351 | 24 | 515 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Carisma Transmed Srl